Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Renal Cell Carcinoma
Squamous Cell Carcinoma of the Head and Neck
Colorectal Carcinoma
Small Cell Lung Cancer
Pancreatic Ductal Adenocarcinoma
Triple-negative Breast Cancer

Interventions

DRUG: JANX008

Sponsor

Janux Therapeutics